Laws & Regulations

Trump Administration Targets Fraud in Medicare Genetic Testing
Regulatory & Compliance Trump Administration Targets Fraud in Medicare Genetic Testing

The Medicare Trust Fund currently faces an unprecedented fiscal challenge as molecular diagnostic costs climb toward a point where regulatory intervention is no longer optional but a matter of national economic survival. The Trump administration has launched an aggressive campaign to overhaul the

How Will the New FDA Dashboard Improve Product Safety?
Regulatory & Compliance How Will the New FDA Dashboard Improve Product Safety?

James Maitland is a leading voice in the intersection of medical technology and regulatory efficiency, bringing a deep understanding of how data architecture can redefine patient safety. With a career dedicated to integrating IoT and robotics into healthcare settings, he offers a unique perspective

Safety-Net Providers Adopt AI to Combat Medicaid Funding Cuts
Regulatory & Compliance Safety-Net Providers Adopt AI to Combat Medicaid Funding Cuts

The sudden silence of a clinic waiting room often signals a crisis of access rather than a successful day of scheduling for the nation's most vulnerable patients. Across the United States, healthcare organizations that serve low-income populations are facing an unprecedented administrative storm

US to Penalize Health IT Firms for Information Blocking
Regulatory & Compliance US to Penalize Health IT Firms for Information Blocking

A New Era of Accountability in Medical Data Exchange The American healthcare landscape is currently undergoing a seismic shift as federal regulators move from mere warnings to aggressive enforcement of data-sharing laws. For years, the promise of seamless medical record portability remained

Why Did the FDA Limit Wellcovorin to a Rare Brain Disorder?
Regulatory & Compliance Why Did the FDA Limit Wellcovorin to a Rare Brain Disorder?

James Maitland is a leading expert in the integration of technology and pharmaceutical policy, with a career dedicated to navigating the complex intersection of medical innovation and regulatory standards. His work often focuses on how historical data and modern clinical demands converge to shape

ARPA-H Launches Delphi Program for Advanced Health Biosensors
Regulatory & Compliance ARPA-H Launches Delphi Program for Advanced Health Biosensors

The traditional model of reactive medicine, where patients only seek care after symptoms become unbearable, is rapidly being replaced by a sophisticated ecosystem of continuous physiological monitoring. Instead of relying on sporadic clinic visits that offer only a momentary snapshot of health, the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later